IGBP1P5

Across TCGA pan-cancer cohorts, IGBP1P5 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated IGBP1P5 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher IGBP1P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IGBP1P5 expression acts as an unfavorable survival marker, although some lineages such as BLCA and SARC show a favorable association.

UCS, LIHC, and BLCA are the cancer types where IGBP1P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	II,III,IV	0.077	0.630	<.001	72	view →
LIHC	OS	Tertile	All	0.025	0.775	<.001	54	view →
BLCA	OS	Tertile	II,III,IV	0.934	0.402	.010	45	view →
KIRC	DFS	Tertile	II,III,IV	0.488	0.779	.005	42	view →
LUSC	OS	Tertile	II,III,IV	0.408	0.805	.005	36	view →
LGG	DFS	Tertile	All	0.440	0.734	.011	30	view →
READ	DFS	Tertile	All	0.163	0.578	.005	27	view →
SARC	DFS	Tertile	All	0.823	0.454	.019	15	view →
STAD	DFS	Quartile	II,III,IV	0.463	0.725	.009	12	view →
GBM	DFS	Tertile	All	0.324	0.171	.009	9	view →
THCA	DFS	Tertile	IV	0.075	0.807	<.001	9	view →
SKCM	DFS	Tertile	All	0.888	0.728	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

IGBP1P5–UCS (OS)

Open the UCS breakdown →